Document Detail

Low- and ultra-low-molecular-weight heparins.
MedLine Citation:
PMID:  15171959     Owner:  NLM     Status:  MEDLINE    
Heparins and low-molecular-weight heparins (LMWHs) have been the mainstay for the prevention and management of venous and arterial thromboembolic disease. In particular, the LMWHs have become well established in the past 15 years for the prevention of thrombosis in medium- and high-risk surgical and medical patients and in the initial management of venous thromboembolism (VTE). They have also been widely evaluated and adopted in clinical practice in the management of patients with acute coronary syndromes. More recently, a variety of heparin-like drugs have been evaluated as potential antithrombotic agents, and the synthetic pentasaccharide (fondaparinux) has been developed and evaluated for the prevention and treatment of VTE.
Ajay K Kakkar
Related Documents :
1577649 - Ejaculatory failure associated with aortic-iliac thrombosis in two stallions.
19412729 - The clinical significance of the lack of arterial or venous thrombosis in patients with...
8902459 - Symptomatic inferior vena cava filter thrombosis: clinical study of 30 consecutive cases.
22943319 - Spontaneous resolution of an inferior epigastric artery pseudoaneurysm secondary to sur...
15634269 - Elevated levels of fviii:c within families are associated with an increased risk for ve...
10369999 - Percutaneous ilio-caval thrombectomy with the amplatz device: preliminary results.
1785339 - Kawasaki disease. with particular emphasis on arterial lesions.
11229159 - Hepatic artery mycotic aneurysm of tubercular aetiology.
3280159 - Clinical implications of internal mammary artery bypass grafts: the coronary artery sur...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Best practice & research. Clinical haematology     Volume:  17     ISSN:  1521-6926     ISO Abbreviation:  Best Pract Res Clin Haematol     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-06-02     Completed Date:  2005-02-02     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  101120659     Medline TA:  Best Pract Res Clin Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  77-87     Citation Subset:  IM    
Department of Surgical Oncology and Technology, Faculty of Medicine, Imperial College, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Heparin / therapeutic use*
Heparin, Low-Molecular-Weight / therapeutic use
Neoplasms / drug therapy
Thrombosis / drug therapy,  prevention & control
Treatment Outcome
Reg. No./Substance:
0/Heparin, Low-Molecular-Weight; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Platelet glycoprotein IIb/IIIa inhibitors.
Next Document:  Fondaparinux: a new synthetic and selective inhibitor of Factor Xa.